OPKO Health, Inc. 13D and 13G filings for GeneDx Holdings Corp.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-11-20 9:36 pm Sale | 2024-11-18 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 1,370,841 4.990% | -375,833 (-21.52%) | Filing |
| 2024-11-08 5:23 pm Sale | 2024-11-06 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 1,746,674 6.360% | -425,000 (-19.57%) | Filing |
| 2024-09-18 4:13 pm Sale | 2024-09-16 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 2,171,674 8.060% | -330,472 (-13.21%) | Filing |
| 2024-08-23 5:33 pm Sale | 2024-08-22 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 2,502,146 9.290% | -309,637 (-11.01%) | Filing |
| 2024-08-12 6:27 pm Sale | 2024-08-08 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 2,811,783 10.440% | -311,620 (-9.98%) | Filing |
| 2024-07-26 7:43 pm Sale | 2024-07-24 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 3,123,403 11.940% | -346,118 (-9.98%) | Filing |
| 2024-07-05 4:14 pm Purchase | 2024-07-03 | 13D | GeneDx Holdings Corp. WGS | OPKO HEALTH INC. OPK | 3,469,521 13.270% | 3,469,521 (New Position) | Filing |